Séverine graduated in 2025 as a chemical engineer from the École Nationale Supérieure de Chimie de Montpellier (ENSCM), with a specialization in Chemistry and Biology for Health, and also obtained a Master’s degree in Translational Medicinal Chemistry from the University of Montpellier.

As part of her training, she spent a semester abroad in 2023 at the University of Turin, Italy, where she attended courses and developed an interest in advanced research topics such as extracellular vesicles for precision medicine and regenerative medicine using stem cells.

She also completed a gap year during 2023–2024. In the first semester, she joined Merck in Switzerland for an internship in microbiological quality control, and in the second semester, she worked at CEA Paris-Saclay on the magnetic sorting of murine immune cells using microfluidic chips, as part of the PhD project of Fanny Rousseau.

For her final-year internship, she joined Sanofi in Marcy-l’Étoile within the team of Dr. Alice Grangier, where she contributed to the development of a biophysical method for the characterization of lipid nanoparticles contained in mRNA vaccines at the single-particle level.

Currently, Séverine is pursuing a PhD at the Institut des Biomolécules Max Mousseron (IBMM), under the supervision of Prof. Hervé Cottet and Dr. Laurent Leclercq (CNRS Researcher). Her research focuses on the characterization of lipid nanoparticles for mRNA delivery, with particular emphasis on studying their protein corona using capillary electrophoresis and Taylor dispersion analysis.